Hundreds of thousands of movies and television series are released every year to the joy of local audiences, but to the annoyance of global audiences who have to wait a long time before these are available in their country. This is because distributors need to take them through an intensive and complex compliance check for every market before they distribute. Our company, Visualyst, is helping publishers get more movies and series cleared for distribution to consumers faster using artificial intelligence and machine learning.

Manolin is a software company focusing on digital health management to accelerate resource sharing between salmon farms. We are a software and data analytics company helping global aquaculture scale sustainably. 🌊 Our ocean faces many challenges, but it holds even more potential for positive impact. Our goal is to help build a more sustainable future food system together with aquaculture farmers.

Waste management solutions. Primary machines and equipment, but also consulting. We make a profit by helping customers reduce their costs (and even make a profit). Enterprises can save/make money by focusing on the environment.  Both parties win. Eco-Nor Group may consider investors to cooperate with good and long-term partners as a matter of urgency.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

The founder of Dynamisk Helse, Ann-Kristin Johansen, worked for several years as a nurse in hospitals and elderly care organizations. She experienced first-hand the lack of proper training which sometimes led to negative incidences for the patients as well as the staff. Sometimes the result had devastating outcomes, with a person's life at risk. Ann-Kristin felt sad and angry and felt the need to personally take action. This resulted in the foundation of Dynamisk Helse AS in 2011. We believe in small drops of theoretical and practical case-specific training, tailored naturally into our daily work. As there was no software platform available we felt was appropriate, we made it ourselves. Starting with making the “Drops first aid” app, which received fantastic feedback around the globe. (still available in Appstore) After this first test of response, we continued developing our own philosophy into a software platform that exceeds normal standards today. With limitless scalability and access on all digital surfaces. The number of elderly and inhabitants with chronic diseases, is going to double within ten years, resulting in dramatic demand for qualified healthcare workers. The leaders in healthcare struggle with high turnover and a shortage of both time and recourses to train the temps. Drops smartphone solution gives access to short and precise information about what to do when they need it, by scanning a QR code. Our Drops Skill aid system enables healthcare leaders to support staff in day-to-day tasks. We save costs for our customers, and provide a better service for patients, while we support care workers in building their skills and confidence.

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

Our mission is to create shareholder value by developing disruptive innovation to commercial products together with industrial partners The development of environmentally friendly fuels shows that there will be several types of fuels with different availability across the globe. The situation is unclear to all affected parties: Shipping companies, truck owners, engine manufacturers and the authorities

Pixotope Technologies is an international, award-winning technology and service company headquartered in Norway. Our flagship product Pixotope® is the world’s leading mixed reality solution for media production that allows media producers and content creators to produce exciting mixed reality content for television, online streaming, and film. Our product and services have been used in some of the largest live productions made in the last few years, such as the Superbowl, League of Legends Championship broadcasts, Euro-vision, and The Weather Channels mixed reality experiences. A selection of these productions can be viewed on our website: https://www.pixotope.com/customers We are a global company with headquarters in Oslo and branch offices in Los Angeles, London, Madrid, and Zagreb. Our customers are from every corner of the world.

OK, Self-Storage Group consists of the brand's City Self-Storage and OK Minilager. We have more than 60 locations in Scandinavia. We aspire to be the leading company in tech in our industry. We have just closed funding from several investors, and we have an ambitious growth plan for the years to come.

ZEN OCEANS is a startup developing fully electric, autonomous-ready ships to affordably decarbonize ocean transport. We will think big and nudge the market for fully electric ships from 0 to 1. To fund our vision, we will develop products that in themselves can scale into large revenue-generating operations; among them maritime batteries (ZENERGY) and autonomy solutions (OCEANEYE). The future of ocean shipping is simple, safe, and sustainable - the frictionless fabric of global trade. Consequently, we consider the argument for electric and autonomous ships to be very strong. We envision a fleet of electric ships deployed at scale, coordinated by an intelligent network for the efficient movement of goods. The future starts now. Maritime batteries: We develop safe and low-cost maritime batteries for large energy systems. Type approval by DNV is ongoing. Fully electric ships: We develop energy- and cost-effective electric ship concepts for short sea trade and more. If you want to learn more, please reach out to us!

Guldstoev consulting group is a company that works for both private and public companies. We are a group of experts within the development of digital solutions. We work with both software, networks and optimization of existing solutions. We work both with existing technologies and work on developing our own tools that can be used by other consulting houses to shape the digital world in 2023.

At Hintly we're on a mission to help sales teams target the right customers, thus helping good companies succeed and creating more relevance in the market. We've spent years building a killer product that is now proven with international customers, and we're ready to take over the world 🚀 Hintly is a Copenhagen-based SaaS tool that helps sales teams identify the best prospects in the market (the needles in the haystack). The solution utilises mountains of data and machine learning to generate an intelligent lead score based on +600 data fields. Our customers experience: 🎯 Tremendoust boost in conversion rates (e.g. meetings booked) 📈 Increase in sales rep efficiency 🕵‍♂️ Identifying great customers outside their original scope

At BARK™DNA we believe that a confident appearance empowers us to own our presence. We want to be the obvious choice for the man who wants to put his best forward. We are the next-generation skincare brand aiming to redefine skincare for men. We confront stereotypes and introduce hybrid skincare solutions that instantly camouflages issues while at the same time offering the appropriate dermatological treatment for men’s unique skin. At BARK™DNA we are chasing a window of opportunity. Non have darted taking the risk to challenge status quo in the conservative men’s cosmetic industry which are struggling with a low degree of innovation. We won’t have that! Men deserve skincare that is formulated for their needs. And they deserve solutions that work.

EIT Climate-KIC (Knowledge and Innovation Community) is Europe’s foremost climate innovation initiative. We understand that keeping global temperature rise below 1.5˚C demands unprecedented change. It requires new social dynamics, ways of doing business, capital flows, policymaking, economic models, and new ways of living. That is why our mission is to leverage the power of systems innovation to transform whole places, industries, and value chains by 2030, working across sectors to develop and scale ambitious, mission-led programmes. Established in 2010 and headquartered in Amsterdam, we orchestrate a community of more than 200 organisations including large corporations and SMEs, municipal and regional governments, universities, and research institutes, as well as non-governmental organisations and uncommon actors. Historically, we have been funded by our founder and core funder, the European Institute for Innovation and Technology (EIT), but we are currently transitioning to a multi-funder model. EIT Climate-KIC colleagues are based in one of our local offices across Europe or work remotely from home based in one of the countries where we have a branch. We meet at our local offices to exchange and connect and use online collaboration tools work with each other and with our Community. On occasion, we meet in-person as teams, and once per year as an organisation.